Crinetics Pharmaceuticals (CRNX) Asset Utilization Ratio (2018 - 2026)

Crinetics Pharmaceuticals' Asset Utilization Ratio history runs 9 years deep, the most recent figure standing at 0.01 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 2529.91% year-over-year to 0.01; the TTM figure through Mar 2026 stood at 0.01 (up 2529.91% YoY), while the FY2025 annual figure was 0.01, up 498.72% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.01, up from 0.01 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.02 in Q2 2023, with the low at 0.0 in Q1 2025.
• The 5-year median for Asset Utilization Ratio is 0.01 (2025), against an average of 0.01.
• The sharpest annual moves came in 2022 and 2024: Asset Utilization Ratio surged 3900.67% in 2022, then slumped 90.91% in 2024.
• Crinetics Pharmaceuticals' Asset Utilization Ratio stood at 0.01 in 2022, then sank by 51.1% to 0.01 in 2023, then sank by 86.06% to 0.0 in 2024, then soared by 656.56% to 0.01 in 2025, then jumped by 115.71% to 0.01 in 2026.
• Business Quant data shows CRNX's Asset Utilization Ratio at 0.01 in Q1 2026, 0.01 in Q4 2025, and 0.0 in Q3 2025.